Webinar on January 31: Claims-Based Quality Reporting for MIPS
uroMedics Pharma LLC Issues Voluntary Nationwide Recall of Levofloxacin in 5% Dextrose 250mg/50mL Due to Presence of Visible Particulate Matter Tentatively Identified as Mold
Center for Medicare and Medicaid Services (CMS) Data Submission Rollout Announcement
Advocacy Action Center: Act Now: Urge Congress to Immediately Repeal the Medicare Part B Outpatient Therapy Caps
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older
Act Now: Urge Congress to Immediately Repeal the Medicare Part B Outpatient Therapy Caps
Pharmedium Services, LLC Expands Voluntary Nationwide Recall of Additional Lots of Compounded Sterile Products Within Expiry Due to Lack of Sterility Assurance
International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A
Call for Nominations for CMS Technical Expert Panel
AAPM&R Submits Comments to CY 2018 Updates to the Quality Payment Program Final Rule
Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Product Ampicillin and Sulbactam for Injection USP 1.5 g/ Vial, Due to Presence of Glass Particles in the Vial
“Pass-Through” Medical Practices Impacted by the Tax Bill
Compounded Sterile Products by PharMEDium Services: Recall - Lack of Sterility Assurance
SQOD Designated as a Qualified Clinical Data Registry by CMS
Anthem Reduces Payments for E&M Visits with Modifier 25
Apply by May 1 for Foundation Research Grants
AAPM&R Members in the News: December 2017
Medicare Finalizes Payment Updates Effective January 2018
Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Linezolid Injection 600mg/300ml, due to Presence White Particulate Matter that has been Identified as Mold
AAN Publishes Child Neurology Measure Set